{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Fang Y"],"funding":["NIA NIH HHS","American Diabetes Association","National Institute on Aging"],"pagination":["2835-2850"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10643448"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["45(5)"],"pubmed_abstract":["Senolytic treatment in aged mice clears senescent cell burden leading to functional improvements. However, less is known regarding the effects of these compounds when administered prior to significant senescent cell accumulation. From 4-13 months of age, C57BL/6 male and female mice received monthly oral dosing of either 100 mg/kg Fisetin or a 5 mg/kg Dasatinib (D) plus 50 mg/kg Quercetin (Q) cocktail. During treatment, several aspects of healthy aging were assayed including glucose metabolism using an insulin and glucose tolerance test, cognitive performance using Morris water maze and novel object recognition, and energy metabolism using indirect calorimetry. Afterwards, mice were euthanized for plasma, tissue specific markers of senescence-associated secretory phenotype (SASP), and whit"],"journal":["GeroScience"],"pubmed_title":["Sexual dimorphic metabolic and cognitive responses of C57BL/6 mice to Fisetin or Dasatinib and quercetin cocktail oral treatment."],"pmcid":["PMC10643448"],"funding_grant_id":["R01 AG057767","R21 AG062985","R01 AG061937","R21AG062985","R01AG061937","1-19-IBS-126","R01AG057767"],"pubmed_authors":["Fang Y","Peck MR","Hascup ER","Medina D","Quinn K","Bartke A","Stockwell R","Hascup KN","McFadden S"],"additional_accession":[]},"is_claimable":false,"name":"Sexual dimorphic metabolic and cognitive responses of C57BL/6 mice to Fisetin or Dasatinib and quercetin cocktail oral treatment.","description":"Senolytic treatment in aged mice clears senescent cell burden leading to functional improvements. However, less is known regarding the effects of these compounds when administered prior to significant senescent cell accumulation. From 4-13 months of age, C57BL/6 male and female mice received monthly oral dosing of either 100 mg/kg Fisetin or a 5 mg/kg Dasatinib (D) plus 50 mg/kg Quercetin (Q) cocktail. During treatment, several aspects of healthy aging were assayed including glucose metabolism using an insulin and glucose tolerance test, cognitive performance using Morris water maze and novel object recognition, and energy metabolism using indirect calorimetry. Afterwards, mice were euthanized for plasma, tissue specific markers of senescence-associated secretory phenotype (SASP), and whit","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Oct","modification":"2026-06-03T11:50:30.919Z","creation":"2025-04-04T13:15:33.894Z"},"accession":"S-EPMC10643448","cross_references":{"pubmed":["37296266"],"doi":["10.1007/s11357-023-00843-0"]}}